Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arrhythmic risk stratification in psoriatic arthritis: a retrospective, electrogram-based comparative analysis.

RMD open·2026
Same author

Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy and Renal Impairment: Analyses From HELIOS-B.

Journal of cardiac failure·2026
Same author

Unraveling the impact of common medications on biomarker patterns in Alzheimer's disease and mild cognitive impairment.

Journal of Alzheimer's disease reports·2026
Same author

QT Interval Evaluation in Right Ventricular Pacing: Validation of a Novel Formula.

Pacing and clinical electrophysiology : PACE·2026
Same author

Sauna Therapy in HFpEF: More than Just Heat?

European journal of heart failure·2026
Same author

Salivary metabolomics for early detection of vascular contributions to cognitive impairment and dementia: Exploring microbiome dysbiosis and sex differences.

Journal of Alzheimer's disease : JAD·2026
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Related Experiment Videos

Update on myocarditis.

Ingrid Kindermann1, Christine Barth, Felix Mahfoud

  • 1Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Kirrberger Strasse 1, Homburg/Saar, Germany. ingrid.kindermann@uks.eu.

Journal of the American College of Cardiology
|February 25, 2012
PubMed
Summary
This summary is machine-generated.

Myocarditis, an inflammatory heart condition, is diagnosed via clinical signs and imaging, with endomyocardial biopsy as the gold standard. While treatment advances, standard strategies for myocarditis are still evolving.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Myocarditis is a heart inflammation often caused by viral infections or immune responses.
  • It is a significant global cause of dilated cardiomyopathy.
  • Diagnosis relies on clinical presentation, noninvasive methods like cardiovascular magnetic resonance imaging, and gold-standard endomyocardial biopsy.

Purpose of the Study:

  • To review the current understanding of myocarditis diagnosis, pathophysiology, and treatment.
  • To highlight the diagnostic and prognostic value of endomyocardial biopsy.
  • To discuss the evolving treatment strategies for acute and chronic myocarditis.

Main Methods:

  • Review of clinical presentations and diagnostic modalities for myocarditis.
  • Emphasis on the role of cardiovascular magnetic resonance imaging and endomyocardial biopsy.
  • Analysis of current therapeutic approaches, including standard heart failure management, physical rest, and potential immunomodulatory therapies.

Main Results:

  • Endomyocardial biopsy provides crucial diagnostic and prognostic information.
  • Standard heart failure therapy and rest are mainstays for acute myocarditis.
  • Immunosuppressive therapy shows promise for chronic, virus-negative inflammatory cardiomyopathy.

Conclusions:

  • Despite diagnostic advancements, standard treatment strategies for myocarditis remain undefined.
  • Mechanical support or heart transplantation may be required in severe cases.
  • Further randomized controlled studies are essential to establish the role of immunosuppressive and immunomodulating therapies in myocarditis treatment.